Test Price
2,000 AEDโ Home Collection Available
Microarray 60K (POC) + Single Karyotyping in UAE โ Comprehensive Genomic Analysis for Recurrent Pregnancy Loss
Executive Summary & Core Metrics
High-Resolution Chromosomal Analysis with 99.9% Diagnostic Sensitivity
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO-accredited microarray and karyotyping protocols.
- Clinical Guidance: Telephonic post-test consultation for result interpretation and reproductive planning.
- Insurance: Direct billing verification via WhatsApp +971 54 548 8731.
- Price: 2,000 AED โ all-inclusive with no hidden charges.
Test Overview & Methodology
The Microarray 60K (POC) + Single Karyotyping test combines high-resolution chromosomal microarray analysis with traditional Giemsa-banded karyotyping on products of conception (POC) tissue and parental peripheral blood. This dual-platform approach detects aneuploidies, microdeletions, microduplications, and structural rearrangements down to approximately 100 kb resolution, providing comprehensive genomic insight for recurrent pregnancy loss evaluation.
| Feature | Our Test: Microarray 60K + Karyotyping | Standard Karyotyping Alone |
|---|---|---|
| Precision | 99.9% sensitivity, 60K resolution (detects microdeletions/duplications down to ~100 kb) | ~95% sensitivity, 5โ10 Mb resolution (misses submicroscopic changes) |
| Method | Chromosomal Microarray (Agilent 60K) + Cell Culture + Giemsa-banded Karyotyping | Culture + Giemsa banding only |
| Turnaround Time | 7โ9 business days | 10โ14 business days |
Physician Insight & Safety Protocols
Clinical Insight by Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA Registration ID: 9294403
โRecurrent pregnancy loss carries an immense emotional burden for families. High-resolution microarray combined with karyotyping provides the genomic depth necessary to identify cryptic chromosomal abnormalities that conventional cytogenetics alone would miss. These findings empower clinicians to offer precise recurrence risk counseling and tailor future management strategies. Always interpret results within the full clinical and familial context.โ
Advisory on Sample Collection & Handling
This test analyzes products of conception tissue which requires surgical or procedural extraction within an accredited hospital facility. Parental blood samples are collected via venipuncture. All specimens are transported under temperature-controlled conditions to the ISO-certified laboratory for processing. A valid physician prescription is mandatory prior to sample collection.
Exclusion Criteria & Clinical Red Flags
- This test is not indicated for routine pregnancy monitoring or as a standalone diagnostic tool without correlation with clinical and imaging findings.
- Not suitable for patients who have had recent blood transfusions or bone marrow transplants that may interfere with microarray results.
- If you experience severe bleeding, fever, or acute pelvic pain following tissue collection, seek immediate emergency medical attention.
- Results should be reviewed in conjunction with a medical genetics consultation; do not alter reproductive plans without professional guidance.
Patient FAQ & Clinical Guidance
1. What is the purpose of the Microarray 60K (POC) + Single Karyotyping test?
This test identifies chromosomal microdeletions, duplications, and aneuploidies in products of conception and parental blood to determine genetic causes of recurrent pregnancy loss. The combined microarray and karyotyping approach delivers a comprehensive genomic assessment to guide recurrence risk counseling and future pregnancy management.
2. How is the sample collected, and does it require a hospital visit?
Products of conception tissue is obtained during a surgical procedure (e.g., dilation and curettage) performed in an accredited hospital. Parental blood samples are drawn by venipuncture. Hospital extraction is required for the tissue specimen; mobile home phlebotomy is not available for this test due to the invasive nature of tissue collection.
3. When will I receive my results, and how are they communicated?
Results are typically available within 7 to 9 business days. You will receive a telephonic consultation with a genetics specialist to discuss the findings and their implications for future reproductive planning. Urgent requests can be prioritized; contact our WhatsApp support for expedited handling.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates in full compliance with UAE federal data protection and healthcare regulations. Patient genetic and clinical data are handled under the framework of Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All laboratory procedures adhere to quality and safety standards required by the Dubai Health Authority (DHA).
Clinical testing and patient consent protocols follow Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring that every step from sample collection to result disclosure is conducted with the highest ethical and legal safeguards.
Clinical & Logistical Metadata
| Test Name | Microarray 60K (POC) + Single Karyotyping |
| Price (AED) | 2,000 AED |
| Turnaround Time | 7โ9 Business Days |
| Sample Type / Matrix | Products of Conception (POC) Tissue & Parental Peripheral Blood |
| Methodology Used | Chromosomal Microarray (Agilent 60K) + Cell Culture + Giemsa-banded Karyotyping |
| ICD-10-CM Code | O26.86 |
| LOINC Code | 81264-9 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians